Perpetual V(D)J recombinase activity involving multiple DNA double-strand break events in B-cell lineage leukemia and lymphoma cells may introduce secondary genetic aberrations leading towards malignant progression. Here, we investigated defective negative feedback signaling through the (pre-) B-cell receptor as a possible reason for deregulated V(D)J recombinase activity in B-cell malignancy. On studying 28 cases of pre-Blymphoblastic leukemia and 27 B-cell lymphomas, expression of the (pre-) B-cell receptor-related linker molecule SLP65 (SH2 domain-containing lymphocyte protein of 65 kDa) was found to be defective in seven and five cases, respectively. SLP65 deficiency correlates with RAG1/2 expression and unremitting V H gene rearrangement activity. Reconstitution of SLP65 expression in SLP65-deficient leukemia and lymphoma cells results in downregulation of RAG1/2 expression and prevents both de novo V H -DJ H rearrangements and secondary V H replacement. We conclude that iterative V H gene rearrangement represents a frequent feature in B-lymphoid malignancy, which can be attributed to SLP65 deficiency in many cases.
Perpetual V(D)J recombinase activity involving multiple DNA double-strand break events in B-cell lineage leukemia and lymphoma cells may introduce secondary genetic aberrations leading towards malignant progression. Here, we investigated defective negative feedback signaling through the (pre-) B-cell receptor as a possible reason for deregulated V(D)J recombinase activity in B-cell malignancy. On studying 28 cases of pre-Blymphoblastic leukemia and 27 B-cell lymphomas, expression of the (pre-) B-cell receptor-related linker molecule SLP65 (SH2 domain-containing lymphocyte protein of 65 kDa) was found to be defective in seven and five cases, respectively. SLP65 deficiency correlates with RAG1/2 expression and unremitting V H gene rearrangement activity. Reconstitution of SLP65 expression in SLP65-deficient leukemia and lymphoma cells results in downregulation of RAG1/2 expression and prevents both de novo V H -DJ H rearrangements and secondary V H replacement. We conclude that iterative V H gene rearrangement represents a frequent feature in B-lymphoid malignancy, which can be attributed to SLP65 deficiency in many cases. Oncogene (2006 Oncogene ( ) 25, 5180-5186. doi:10.1038 published online 24 April 2006 Keywords: V(D)J recombination; pre-B cell receptor; leukemia; SH2-domain; DNA rearrangement Perpetual V(D)J recombinase activity continuously generates DNA double-strand breaks and may give rise to secondary transforming events during the malignant progression of early leukemia and lymphoma cells (Khanna and Jackson, 2001) . In B-cell precursors, V(D)J recombination is regulated through a negative feedback signal: upon successful rearrangement, a m-heavy chain encoded by a productively rearranged V H region gene signals termination of recombination activity at the IGHV locus (Grawunder et al., 1995) . How this negative feedback signal is deranged in leukemia and lymphoma cells is not yet resolved.
Recent work demonstrated that deficiency of SLP65 (SH2 domain-containing lymphocyte protein of 65 kDa) is a frequent feature in acute lymphoblastic leukemia cells (Jumaa et al., 2003; Klein et al., 2004) . Although a recent report questioned these findings (Imai et al., 2004) , this study shows that defective SLP65 expression is not only frequent in human pre-B-lymphoblastic leukemia but also occurs in a fraction of mature B-cell lymphoma cases. Identifying three leukemia and one lymphoma cell line lacking expression of functional SLP65, we studied the contribution of SLP65 to the control of the V(D)J recombinase activity in B-cell lineage leukemia and lymphoma cells.
Perpetual V(D)J recombinase activity in B-cell lineage leukemia and lymphoma cells
In order to investigate ongoing V(D)J recombinase activity in B-cell precursor leukemia and B-cell lymphoma cells, we first analysed the configuration of immunoglobulin (Ig) gene loci in leukemia and lymphoma cell lines. Among 22 clonal pre-B-lymphoblastic leukemia and B-cell lymphoma cell lines, five of 12 pre-Blymphoblastic leukemia and two of 10 B-cell lymphoma cell lines express RAG1 and RAG2, and carry more than two productively rearranged Ig heavy chain V region genes, indicating that negative feedback signaling of the (pre-) B-cell receptor to V(D)J recombinase activity was impaired in these cells (Table 1 ). In (pre-) B-lymphoblastic cell lines harboring only one productively rearranged IGHV allele, expression of RAG1 and RAG2 does not necessarily indicate defective negative feedback signaling of the (pre-) B-cell receptor and may also reflect active rearrangement of IGKV and IGLV light chain genes. In addition, ongoing V(D)J recombinase activity represents a typical feature of pre-B-lymphoblastic leukemia cells carrying a BCR-ABL1 gene rearrangement as previously shown by us and others (Height et al., 1996; Klein et al., 2004) , suggesting that BCR-ABL1 kinase activity interferes with negative feedback signaling of the pre-B-cell receptor (Klein et al., 2004) . 
Pre-B ALL TEL-PDGFRB In murine B cells, the (pre-) B-cell receptor-associated linker molecule SLP65 is required to downregulate V(D)J recombinase activity (Hayashi et al., 2003) and acts as a tumor suppressor in pre-B-lymphoblastic leukemia cells (Jumaa et al., 2003) . Studying SLP65 expression in B-cell precursor leukemia and B-cell lymphoma by Western blot, we found that expression of SLP65 protein was defective in seven of 28 leukemia cases (four of 16 primary cases and three of 12 cell lines; Figure 1a ) and five of 27 lymphomas (four of 17 primary cases and one of 10 cell lines; Figure 1a ). Sequence analysis revealed that SLP65 transcripts frequently lost their coding capacity for full-length SLP65 protein owing to aberrant splicing with exon skipping and usage of cryptic splice sites and splice site slippage (Table 1 ). In one case of diffuse large B-cell lymphoma (DLBCL) (Karpas-422), aberrant splicing was the result of a genomic deletion of the 3 0 splice site of exon 3 of the SLP65 gene (Figure 1b ). Owing to a 28 bp deletion of the 3 0 part of exon 3 and the 5 0 part of introns 3-4, fulllength SLP65 can no longer be expressed from this allele. Of note, the second SLP65 allele in these DLBCL cells was lost owing to a large deletion at 10q23 (R Siebert, unpublished). Chromosomal deletion and loss of heterozygosity by somatic mutation is consistent with a role of SLP65 as a tumor suppressor gene in these DLBCL cells. Sequence analysis of the coding region of SLP65 and intronic splice sites revealed a number of other somatic mutations leading to amino-acid changes or loss of the reading frame (Table 1) . Somatic mutations of the SLP65 gene were amplified from BEL1, BV173, SUP-B15 and HPB-NULL cells (Table 1A) . Non-functional SLP65 mRNA splice variants were amplified from all cases of B-cell lineage leukemia and lymphoma lacking negative feedback signaling through the (pre-) B-cell receptor (ongoing RAG expression together with multiple V H gene rearrangements; Table 1 ). These findings suggest that SLP65 is required to halt the recombination machinery upon successful VDJ rearrangement at the IGHV locus.
V H replacement in SLP65-deficient leukemia and lymphoma cells
As previously shown by us and others (Zhang et al., 2003; Klein et al., 2004) , perpetual V(D)J recombinase activity may involve de novo V H to DJ H rearrangements or secondary rearrangements by replacement of a previously rearranged V H gene segment by a yet unrearranged upstream V H gene segment. In this case, a previously rearranged V H gene segment is cleaved at a cryptic recombination signal sequence (RSS) in its 3 0 part with only 5-7 bp remaining as a relict of the initially rearranged V H gene segment. Such footprints could indeed be detected in the IGH (immunoglobulin heavy chain) VDJ rearrangements of five pre-B-lymphoblastic leukemia cell lines (BEL1, BV173, SUP-B15, Nalm1 and HPB-NULL) and one B-cell lymphoma cell line (Karpas-422; Table 2 ). In two of these five cell lines, the leukemia cells exhibit expression of SLP65. Ongoing V(D)J recombinase activity in these two cases (SUP-B15 and Nalm1), despite expression of SLP65, reflects that these leukemia cells express the oncogenic BCR-ABL1 kinase, which interferes with negative feedback signaling of the pre-B-cell receptor (Klein et al., 2004) .
To test if de novo rearrangement and V H replacement are caused by SLP65 deficiency, we reconstituted SLP65 expression in SLP65-deficient pre-B-lymphoblastic leukemia cells (BEL1) and diffuse large B-cell lymphoma cells (Karpas-422) by nucleofection. After 2 days, SLP65-reconstituted cells were sorted and analysed for expression of RAG1 and RAG2 and the presence of short-lived DNA double-strand break intermediates at RSSs flanking V H and J H gene segments. . Amplification and sequencing of SLP65 was performed as described previously , using the primer pairs listed in Supplementary Table 1. Sequence data is available from EMBL/GenBank under accession number AM180347. The second SLP65 allele is missing in a classical loss of heterozygosity situation owing to a large chromosomal deletion at 10q23. A detailed description of the cell lines used is given in Table 1 and in Supplementary information.
(pre-) B-cell receptor signaling in SLP65-deficient B-cell malignancy M Sprangers et al The footprint of this potential V H replacement may also be derived from a V H 3-74 or V H 6-1 gene segment. The D H gene segment could not be identified.
d Likely generated by inversion or transrecombination events.
(pre-) B-cell receptor signaling in SLP65-deficient B-cell malignancy RSS-DNA double-strand break intermediates specific for yet unrearranged J H 5 gene segments were amplified to detect de novo D H to J H 5 rearrangements (Supplementary Figure 1 ). For detection of secondary rearrangements by V H replacement, we amplified DNA double-strand break intermediates at the cryptic RSS of an already rearranged V H gene segment (V H 1-2 in BEL1 cells and V H 6-1 in Karpas-422 cells; Figure 2a ; Supplementary Figure 1 ). To ensure that the amount of target DNA for double-strand breaks was equal, a germline DNA fragment including the J H 5 RSS (de novo rearrangements) and the pre-existing VDJ rearrangements (V H 1-2 D H 3-22 J H 6 in BEL1 cells; V H 6-1 D H 3-22 J H 4 in Karpas-422 cells) were amplified. In the case of BEL1 cells, we amplified one germline allele of the IGHV locus in addition to two rearranged alleles (Tables 1 and 2 ), suggesting that this cell line comprises subclones that carry at least one germline allele.
Although DNA double-strand breaks involved in both de novo and secondary rearrangements were clearly detectable in SLP65-deficient leukemia and lymphoma cells carrying a green fluorescent protein (GFP)-control vector, reconstitution of SLP65 expression in these cells resulted in a dramatic decrease of the frequency of DNA double-strand breaks (Figure 2a) . Likewise, SLP65-deficient leukemia and lymphoma cells carrying only the GFP-control vector express both RAG1 and RAG2, which was sensitive to SLP65 reconstitution in these cells (Figure 2b) . We conclude that re-expression of SLP65 in pre-B-lymphoblastic leukemia and lymphoma cells was sufficient to terminate aberrant VDJ recombinase activity. This function of SLP65 may have important implications for the clonal evolution of an SLP65-deficient leukemia or lymphoma because perpetual expression and activity of RAG1 and RAG2 carries the risk of continuous DNA double-strand breaks and the accumulation of secondary transforming events in the leukemia and lymphoma cells. These findings establish a causative link between perpetual VDJ recombinase activity and SLP65 deficiency not only in pre-B-lymphoblastic leukemia but also in B-cell lymphoma cells.
Abbreviations DLBCL, diffuse large B-cell lymphoma; IGH, immunoglobulin heavy chain; RSS, recombination signal sequence; SLP65, SH2 domain-containing lymphocyte protein of 65 kDa.
